Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11692035 Therapeutic CD47 antibodies

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Arch Oncology
Arch Oncology
0
Date Filed
December 4, 2019
0
Date of Patent
July 4, 2023
0
Patent Application Number
16703484
0
Patent Citations
‌
US Patent 7696325 Polypeptide inducing apoptosis
0
‌
US Patent 8101719 Humanized anti-CD47 antibody
0
‌
US Patent 8236313 Prevention of tissue ischemia, related methods and compositions
0
‌
US Patent 8562997 Methods of treating acute myeloid leukemia by blocking CD47
0
‌
US Patent 8759495 Anti-5T4 antibodies and uses thereof
0
‌
US Patent 8951527 Radioprotectants targeting thrombospondin-1 and CD47
0
‌
US Patent 9017675 Humanized and chimeric monoclonal antibodies to CD47
0
‌
US Patent 9221908 Therapeutic CD47 antibodies
0
‌
US Patent 9382320 Humanized and chimeric monoclonal antibodies to CD47
0
‌
US Patent 9518116 Therapeutic CD47 antibodies
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11692035
0
Patent Primary Examiner
‌
Jessica H Roark
0
CPC Code
‌
C07K 16/2803
0
‌
C07K 16/2896
0
‌
C07K 2317/33
0

Find more entities like US Patent 11692035 Therapeutic CD47 antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo